Women Undergoing Third Line Overactive Bladder Treatment Demonstrate Elevated Thermal Temporal Summation

Area of Science:

• Urology
• Neuroscience
• Pain Research

Background:

• Overactive bladder (OAB) is a common condition affecting many women.
• Current treatments for OAB include behavioral therapies, medications, and interventional procedures.
• Understanding the underlying pathophysiology of OAB is crucial for developing more effective treatments.

Purpose of the Study:

• To investigate whether women with overactive bladder (OAB) requiring third-line therapy exhibit increased central sensitization compared to those not yet requiring such advanced treatment.
• To use temporal summation of heat pain stimuli as a biomarker for central sensitization in OAB patients.

Main Methods:

• Quantitative sensory testing was performed on 39 women undergoing third-line OAB therapy (onabotulinumtoxinA or sacral neuromodulation) and 55 women with OAB not yet requiring third-line treatment.
• A thermal temporal summation protocol was employed, measuring responses to 10 heat stimuli at 49°C.
• Linear regression analysis was used to compare temporal summation slopes between the groups.

Main Results:

• Women receiving third-line OAB therapy demonstrated significantly higher standardized temporal summation slopes, indicating greater central sensitization (β = 1.57, p = 0.027).
• Exploratory analyses revealed that a history of incontinence surgery or hysterectomy was associated with increased temporal summation.

Conclusions:

• Elevated temporal summation in women undergoing third-line OAB therapy suggests increased central sensitization.
• These findings point towards potential pathophysiological differences in afferent nerve function and processing in a subset of women with OAB.
• Further research into neural mechanisms may reveal novel therapeutic targets for refractory OAB.